An analysis that integrates three large sets of genomic data available through The Cancer Genome Atlas has identified 37 RNA molecules that might predict survival in patients with the most common form of breast cancer. The study analyzed large masses of data from 466 cases of the most common type of breast cancer and provides the first prognostic signature in cancer composed of both mRNA and microRNA.